Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by bilosellhion Feb 23, 2004 12:18pm
462 Views
Post# 7103020

Reovirus Patents

Reovirus Patentsi did a search on patents filed in Canada on the term reovirus and noted several not issued to onc, including the first one that comes up. (i didn't include the links so this post can't be censored by someone who doesn't like it - to do your own search, go to http: //patents1.ic.gc.ca/intro-e.html and do a basic search and type in reovirus or just go to the yahoo oncy board and follow the links Oncolytic Virus Dec. 1, 2000 & Oct. 5, 2001 patent number=2430495 TREATMENT OF NEOPLASMS WITH VIRUSES Apr. 15, 1999 patent_number=2370187 Treatment of Neoplasms with viruses Oct. 9, 1997 patent_number=2305269 are these examples of what BT was referring to when he said onc was only days ahead of their competitors and that "days mean something?" things that make you go hmmm
Bullboard Posts